BRCA2 and primary biliary cholangitis: This systematic review and meta-analysis of fourteen publications found that RRSO is not associated with a significant reduction in the overall PBC risk or CBC risk in BRCA1 and BRCA2 carriers combined or in BRCA1 carriers alone but is associated with a significant reduction in PBC risk in BRCA2 carriers alone.